Brief: Akari Therapeutics Announces Shareholder Approval In Connection With Peak Bio Merger
08/11/2024 13:01
Nov 8 (Reuters) - Akari Therapeutics PLC AKTX.O :
* AKARI THERAPEUTICS ANNOUNCES SHAREHOLDER APPROVAL IN
CONNECTION
WITH PEAK BIO, INC. MERGER
* AKARI THERAPEUTICS PLC - MERGER TO RESULT IN 50% EQUITY
OWNERSHIP FOR AKARI AND PEAK BIO SHAREHOLDERS
Source text: ID:nGNX3pVZqj
Further company coverage: AKTX.O
(Reuters.Briefs@thomsonreuters.com)
Recent news on Peak Bio
See all newsBrief: Akari Therapeutics Announces Shareholder Approval In Connection With Peak Bio Merger
Brief: Akari Therapeutics And Peak Bio Announce Portfolio Prioritization Plan For Combined Go-Forward Merger Entity
Brief: Peak Bio, Inc. Announces Up-Listing To Otcqb Market
Brief: Peak Bio Announces Its Application To Uplist To The Otcqb Venture Market
Brief: Peak Bio, Inc. Announces Amendment And Continued Access To Equity Line Of Up To $100 Million USD Via An Accelerated Common Stock Purchase Transaction With White Lion Capital